AI-generated summary
The authors report a crossover randomized placebo-controlled pilot study of bright light therapy versus dim light therapy in 23 people with Parkinson's disease, each receiving one month of each intervention. They report improvements in sleepiness, anxiety, quality of life and autonomic function after bright light therapy, and improved visual pathway measures (PERG N95 and VEP P100 latencies) compared with dim light therapy. The abstract does not establish a clear treatment effect on retinal thickness.
- Participants
- 23
- Who or what was studied
- Adults with Parkinson's disease
- Limits stated in the abstract
- The abstract describes a small pilot study of 23 patients, and it does not report wavelengths or clinical effect sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmcpsychiatry.biomedcentral.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Pilot study, Placebo-controlled, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.